Skip to main content

Middle East And Africa Pediatric Healthcare Market Analysis, Size, Growth, Trends, and Outlook 2019 to 2023

 Middle East And Africa Pediatric Healthcare Market Share, Application And Growth Analysis, By Type Of Diseases (Short Term Diseases, Chronic Diseases And Others), By Therapeutics (Cardiology, Allergy And Immunology, Gastroenterology, Infectious Disease And Others), By Treatment (Medication, Surgery, And Others) - Forecast To 2023

Paediatric Healthcare-Overview

Paediatrics is a branch of medicine which deals with diagnosis and treatment of diseases related to paediatric group. It can be classified into the four categories namely neonates (from birth till the first 28 days of life), infants (29 days to 2 years), children (2 years to 12 years) and adolescents (12 years to 18 years). Paediatrician is a medical professional who specializes in providing treating the paediatric group. Paediatric medical devices are devices used for the treatment and care of infants and children below 18 years having some healthcare issues.

Demand for paediatric medical devices is increasing due to high incidence of chronic illnesses among children, high premature birth rate, increasing birth defects among new born, and rising awareness regarding disease conditions among children. Malnutrition among children prevalent in under developed parts of the world is also a major driver of this market. Global Paediatric medical device market is expected to grow at a CAGR of 10.5% during forecast period 2017 to 2023.

Key players in the Paediatric Healthcare:

Hoffmann-La Roche AG (Germany), Medtronic Plc. (U.S.), Bayer AG (Germany), Abbott (U.S.), I-SENS, Inc. (South Korea), Siemens (U.S.) and others. The main focus of these players is tapping the market in developing regions across the globe. Also product differentiation plays an important role for sustaining the growth of key players in the market.

 Avail a Free Sample@ https://www.marketresearchfuture.com/sample_request/2778

Key developments:

Hoffmann-La Roche AG:

June, 2017: F. Hoffmann-La Roche AG acquired mySugr to form a leading platform for digital diabetes management

August, 2015: F. Hoffmann-La Roche AG acquired GeneWEAVE to strengthen offerings in microbiology diagnostics. Roche will pay GeneWEAVE shareholders USD 190 million upfront and up to USD 235 million in contingent product related milestones

February 2015 : F. Hoffmann-La Roche AG announced the collaboration with BioMed X for the development of Nanomaterial-Based Biosensors for Near-Patient Testing

September 2014: F. Hoffmann-La Roche AG launched Elecsys anti-Müllerian Hormone (AMH) fertility test for assessment of ovarian reserve for pregnancy

Medtronic plc.:

October, 2016: Medtronic plc received an approval for its suite of cardiac rhythm and heart failure devices and leads to be scanned in both 3 and 1.5 Tesla (T) magnetic resonance imaging (MRI) machines. This FDA approval will help the company to strengthen its position in MRI machines segment.

December, 2015: Medtronic plc and Samsung came together in an alliance to accelerate the development of digital health solutions for the millions of people suffering from chronic pain, movement disorders, incontinence, and other conditions who could benefit from neuromodulation therapy.

Abbott:

October, 2016 : Abbott announced collaborations with Celgene and Agios for diagnostic identification of IDH mutations. The agreement focuses on the development and commercialize the diagnostic tests.

April, 2016: Abbott received FDA approval for its companion diagnostics “Vysis CLL FISH probe kit” in Leukemia. The kit is used to detect the 17p deletion in chronic lymphocytic leukemia patients, the target population of a new drug from AbbVie.

Siemens:

September, 2016: Siemens launched the combination of the Modularis urological shock wave unit and the flat detector technology of the mobile C-arm Cios Fusion. Since, constantly switching between two or even three different control units would be complicated and could lead to errors, the Modularis' central control unit is a better option. This will help Siemens to strengthen its position in the market.

Access Report Details @  https://www.marketresearchfuture.com/reports/pediatric-Healthcare-market-2778

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Comments

Popular posts from this blog

Transfer Membrane Market Trends, Regional Scope and Growth in Emerging Economies

  Transfer Membrane Research Report: by Type (nitrocellulose transfer membranes, PVDF transfer membranes), by Transfer Method (semi-dry electrotransfers), by Application (western blotting, southern blotting), and by End user - Global Forecast Till 2023 Market Highlights The global transfer membrane anticipated to have held a market value of USD 184.5 million in the year 2017 and is expected to grow at a CAGR of 5.3% during the forecast period. Due to increasing R&D spending by pharmaceutical and biotechnology companies, moreover increasing applications. Companies are using a trend of strategic alliance and acquisition to gain the market and minimize the competition in the market. Intended Audience Biotechnology Companies Research and Development Organization Healthcare Organizations Various research and consulting firms Avail a Free Sample@  https://www.marketresearchfuture.com/sample_request/7389 Additionally, the growing research and development expenditure by the government as w

Big Data In Healthcare Market Top Companies Growth Overview BY Industry Size and Major Segments

Global Big Data In Healthcare Market is anticipated to reflect a positive growth trend in the forthcoming years and reach a significant valuation by the end 2027, reveals Market Research Future (MRFR) in a minutely analyzed research report. Big data in healthcare is gaining prominence as it can be used in the prediction of outcome of diseases prevention, reduce the cost of treatment, and prevent epidemics and in disease development. With the help of big data in predictive analysis, medical issues can be identified and addressed before it becoming an unmanageable problem. Global  Big Data In Healthcare Market  Insights 2020 provides a unique tool for evaluating the Market, highlighting opportunities, and supporting strategic and tactical decision-making. This report recognizes that in this rapidly-evolving and competitive environment, up-to-date Marketing information is essential to monitor performance and make critical decisions for growth and profitability. It provides informati

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Size, Product Scope, Technological Growth and Future Trend 2023

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Size Information By Treatment (Intravenous Immunoglobulin, Corticosteroids, Plasmapheresis (Plasma Exchange), Physiotherapy, Others), Diagnosis (Electrodiagnostic Testing, Nerve Conduction, EMG, Spinal Fluid Analysis, Others), By Route of Administration (Intravenous, Oral, Others), By End User (Hospitals, Specialty Neurological Clinics, Research & Academic Laboratories, Others) and Top Regions Forecast till 2023. The “ Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Size ” In-Depth competition analysis of the major companies in the report, sector of the report includes the market depictions, requirements, and product portrayals, manufacture, competence, contact figures, cost, and revenue. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Size Research Coverage: Changing market dynamics of the industry To get a comprehensive overview of the Chronic Inflammatory Demyelinating Po